Skip to main content
Clinical Trials/ISRCTN53325751
ISRCTN53325751
Completed
未知

Promoting weight loss through diet and exercise in overweight women with breast cancer: a four-arm randomized trial - InForma study

European Institute of Oncology (Italy)0 sites266 target enrollmentOctober 16, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Overweight or obese breast cancer patients
Sponsor
European Institute of Oncology (Italy)
Enrollment
266
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Registry
who.int
Start Date
October 16, 2015
End Date
June 30, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
European Institute of Oncology (Italy)

Eligibility Criteria

Inclusion Criteria

  • 1\. Women aged 18 or older
  • 2\. Written informed consent obtained
  • 3\. Willing to be randomized to either group
  • 4\. Histological breast cancer diagnosis
  • 5\. BMI comprised between 25 and 40 kg/m2
  • 6\. Within one year/6 months of completion of main cancer treatment
  • 7\. Willing to wear the wrist\-based activity monitor during the 6\-month study period

Exclusion Criteria

  • 1\. Unable to find transportation to the study location over the study period
  • 2\. Plan to move away from Lombardy or to be out of town for more than 3 weeks during the study period
  • 3\. Investigator does not approve participation in the study in case of:
  • 3\.1\. History of heart condition, stroke, chest pain during activity or rest
  • 3\.2\. Severe hypertension
  • 3\.3\. Patient is unable to walk for exercise (self\-report)
  • 3\.4\. Symptoms of alcohol or substance dependence
  • 3\.5\. Recent hip fracture, hip or knee replacement, spinal surgery or other orthopedic complications that would prevent optimal participation in the physical activities prescribed
  • 4\. Any other severe medical condition or advanced age impeding the patient to adhere at the planned study follow\-up period
  • 5\. Participant already participates to a physical activity or diet intervention trial

Outcomes

Primary Outcomes

Not specified

Similar Trials